These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19787288)

  • 21. Arterial Stiffness as a Risk Factor for Subclinical Coronary Artery Calcification in Predialysis Chronic Kidney Disease: From the KNOW-CKD Study.
    Hyun YY; Kim H; Oh KH; Ahn C; Park SK; Chae DW; Han SH; Kim YS; Lee SW; Kim CS; Lee KB
    Kidney Blood Press Res; 2019; 44(3):426-434. PubMed ID: 31132783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
    Bellasi A; Kooienga L; Block GA; Veledar E; Spiegel DM; Raggi P
    J Nephrol; 2009; 22(2):255-62. PubMed ID: 19384844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone metabolism regulators and arterial stiffness in postmenopausal women.
    Albu A; Fodor D; Bondor C; Crăciun AM
    Maturitas; 2013 Oct; 76(2):146-50. PubMed ID: 23916080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients.
    Nybo M; Poulsen MK; Grauslund J; Henriksen JE; Rasmussen LM
    Diabet Med; 2010 Mar; 27(3):289-94. PubMed ID: 20536491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
    Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
    Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An association between glucose metabolism status and brachial-ankle pulse wave velocity in Chinese patients with coronary artery disease].
    Shen JJ; Wu YQ; Li J; Hu DY
    Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):995-8. PubMed ID: 19134303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
    Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
    Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between brachial-ankle pulse wave velocity and occult coronary artery disease detected by multi-detector computed tomography.
    Nam HJ; Jung IH; Kim J; Kim JH; Suh J; Kim HS; Kim HK; Jung YJ; Kang JW; Lee S
    Int J Cardiol; 2012 May; 157(2):227-32. PubMed ID: 21315465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study.
    Chae SY; Chung W; Kim YH; Oh YK; Lee J; Choi KH; Ahn C; Kim YS
    J Korean Med Sci; 2018 Dec; 33(53):e322. PubMed ID: 30595681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients.
    Talib A; Nakagawa N; Saito E; Matsuki M; Kobayashi M; Akasaka K; Hirayama T; Ishida H; Sato N; Hasebe N
    Hypertens Res; 2012 Apr; 35(4):426-33. PubMed ID: 22129515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
    Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M
    Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct.
    Guldiken B; Guldiken S; Turgut B; Turgut N; Demir M; Celik Y; Arikan E; Tugrul A
    Thromb Res; 2007; 120(4):511-6. PubMed ID: 17258300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study.
    Godsland IF; Elkeles RS; Feher MD; Nugara F; Rubens MB; Richmond W; Khan M; Donovan J; Anyaoku V; Flather MD;
    Diabet Med; 2006 Nov; 23(11):1192-200. PubMed ID: 17054594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Gamma-glutamyltransferase Levels Predict the Progression of Coronary Artery Calcification in Adults With Type 2 Diabetes Mellitus.
    Gang L; Wei-Hua L; Rong A; Jian-Hong Y; Zi-Hua Z; Zhong-Zhi T
    Angiology; 2015 Aug; 66(7):667-74. PubMed ID: 25163771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients.
    Ishiyama M; Suzuki E; Katsuda J; Murase H; Tajima Y; Horikawa Y; Goto S; Fujita T; Takeda J
    Diabetes Res Clin Pract; 2009 Aug; 85(2):189-96. PubMed ID: 19497632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.
    Berezin AE; Kremzer AA
    Atherosclerosis; 2013 Aug; 229(2):475-81. PubMed ID: 23880208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes.
    Maser RE; Lenhard MJ; Sneider MB; Pohlig RT
    Endocr Pract; 2015 Jan; 21(1):14-22. PubMed ID: 25100392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of coronary artery calcification with MDA-LDL-C/LDL-C and urinary 8-isoprostane in Japanese patients with type 2 diabetes.
    Ono M; Takebe N; Oda T; Nakagawa R; Matsui M; Sasai T; Nagasawa K; Honma H; Kajiwara T; Taneichi H; Takahashi Y; Takahashi K; Satoh J
    Intern Med; 2014; 53(5):391-6. PubMed ID: 24583425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification.
    Pérez de Ciriza C; Moreno M; Restituto P; Bastarrika G; Simón I; Colina I; Varo N
    Clin Biochem; 2014 Dec; 47(18):272-8. PubMed ID: 25218813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.